Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

PhaseBio Pharmaceuticals Inc (PHAS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16
   10-K10-K10-K10-K10-KS-1/A
Revenues  10.80.32.40.70.07.4
            Revenue growth  3284.7%-86.4%253.4% -100.0% 
Cost of goods sold  0.00.00.00.00.09.5
Gross profit  10.80.32.40.70.0-2.1
            Gross margin  100.0%100.0%100.0%100.0% -28.8%
Selling, general and administrative   [+]16.113.111.24.92.32.1
Research and development  102.172.130.915.56.2 
Other operating expenses       5.3
EBITDA   [+]-105.6-84.3-39.6-19.5-8.4-9.4
            EBITDA margin  -974.7%-26358.8%-1675.6%-2925.0% -127.6%
Depreciation and amortization  1.80.50.20.10.10.1
EBIT   [+]-107.4-84.9-39.7-19.6-8.5-9.5
            EBIT margin  -991.2%-26517.5%-1683.0%-2940.7% -128.8%
Interest expense, net   [+]0.91.2-0.53.52.70.0
Other income (expense), net   [+]-21.2-12.50.0-0.71.00.3
Pre-tax income  -129.5-98.6-39.2-23.8-10.2-9.2
Income taxes  1.60.00.00.00.00.0
            Tax rate   0.0%0.0%0.0%0.0%0.0%
Net income  -131.1-98.6-39.2-23.8-10.2-9.2
            Net margin  -1210.1%-30801.6%-1662.3%-3569.8% -125.0%
   
Basic EPS   [+]($2.98)($3.39)($1.43)($4.49)($13.78)($12.41)
Diluted EPS   [+]($2.98)($3.39)($1.43)($4.49)($13.78)($12.41)
   
Shares outstanding (basic)   [+]43.929.127.55.30.70.7
Shares outstanding (diluted)   [+]43.929.127.55.30.70.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy